Boston Scientific Corp. (BSX) Tops Q2 EPS by 8c; Raises FY11 Outlook Above Street, Guides Q3

July 28, 2011 7:05 AM

Boston Scientific Corp. (NYSE: BSX) reported Q2 EPS of $0.17, $0.08 better than the analyst estimate of $0.09. Revenue for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found